Order Entry
Puerto Rico
ContactUsLinkComponent
 
SensoLyte® Rh110 Factor Xa Assay Kit (Fluorimetric), AnaSpec Inc.
  103010-622
 :  
SensoLyte® Rh110 Factor Xa Assay Kit (Fluorimetric), AnaSpec Inc.
  103010-622
 :  AS-72207
 :  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

 

  • Size:
    100 Assays
  • Cat. No.:
    103010-622
  • Storage temperature:
    – 78 °C
  • Includes:
    The assays can be performed in a convenient 96-well microplate format, kit includes essential components and detailed protocol and references
  • Supplier no.:
    AS-72207

 

 

Factor Xa (FXa) is a serine endopeptidase composed of two disulfide-linked subunits

The SensoLyte® Rh110 Factor Xa Assay Kit provides a convenient assay for screening of FXa inhibitors or continuous assay of enzyme activity using a fluorogenic substrate. Upon FXa protease cleavage, this substrate generates the Rh110 (rhodamine 110) fluorophore which has a bright green fluorescence that can be detected at excitation/emission=490 nm/520 nm. The longer-wavelength spectra and higher extinction coefficient of the Rh110 provide greater sensitivity and less interference from other reaction components.

FXa leads to blood clot formation by converting prothrombin to thrombin through the prothrombinase complex. FXa is generated from zymogen Factor X via the intrinsic and extrinsic pathways and is the rate-limiting step in the propagation of thrombin generation. In the presence of Ca2+ ions, FXa forms prothrombinase with factor Va on the phospholipid membrane of the activated platelets. FXa has emerged as an attractive target for drug discovery for thromboembolic diseases.